- Report
- June 2024
- 200 Pages
Global
From €7140EUR$7,950USD£6,115GBP
- Report
- June 2024
- 185 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
- Report
- May 2024
- 185 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
- Report
- April 2023
- 120 Pages
Global
From €4266EUR$4,750USD£3,654GBP
- Report
- May 2022
- 120 Pages
Global
From €3197EUR$3,560USD£2,738GBP
€3996EUR$4,450USD£3,423GBP
- Report
- June 2022
- 946 Pages
Global
From €2245EUR$2,500USD£1,923GBP
- Report
- May 2022
- 112 Pages
Global
From €1796EUR$2,000USD£1,538GBP
- Drug Pipelines
- November 2020
- 3809 Pages
Global
From €2245EUR$2,500USD£1,923GBP
- Drug Pipelines
- April 2023
- 34 Pages
Global
From €8976EUR$9,995USD£7,688GBP
- Report
- April 2024
- 100 Pages
Africa
From €1796EUR$2,000USD£1,538GBP
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
United Kingdom
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
United States
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
China
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
France
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
Germany
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
India
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
Saudi Arabia
From €1347EUR$1,500USD£1,154GBP
- Report
- April 2024
- 80 Pages
South Korea
From €1347EUR$1,500USD£1,154GBP
- Newsletter
- June 2025
- 12 Pages
United States

The Melanoma Drug market is a subset of the larger Skin Cancer Drugs market. It is composed of drugs used to treat melanoma, a type of skin cancer. These drugs are typically used in combination with other treatments such as surgery, radiation, and immunotherapy. Commonly used drugs include targeted therapies, immunotherapies, and chemotherapy. Targeted therapies are designed to target specific molecules in the cancer cells, while immunotherapies are designed to boost the body's own immune system to fight the cancer. Chemotherapy is used to kill cancer cells.
The Melanoma Drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck, Roche, Novartis, and Pfizer. Other companies include AstraZeneca, Eli Lilly, and GlaxoSmithKline. Show Less Read more